CANDEL THERAPEUTICS INC
CADLNASDAQ🏆 #2050 by market capUS Equity
$807.65▲ $18.09 (+2.24%)
Simulated price1h—
24h▲ 2.2%
7d—
14d—
30d—
1y—
🏦Market Cap
$769M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
6204.3x
Expensive
Otter Score
56
Weak
No chart data available for CADL.
Trading Snapshot
- Day Range
- $801.53 – $816.19
- 52-Week Range
- $4.35 – $11.36
- Volume
- $2.23B
- Avg Volume
- $1.70B
- Shares Outstanding
- 73.3M
- Next Earnings
- Oct 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $124,000
- Last Q Revenue
- $30,800
- P/E Ratio
- —
- P/S Ratio
- 6204.3x
- EPS (TTM)
- $-0.98
- Dividend Yield
- —
Why Investors Own CADL
- ✓High-growth profile — revenue up -3.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 32% gross margin and 21% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$124,000▼ −2.6% YoY
Gross Margin (TTM)
32.1%▲ +2.6% YoY
Operating Income (TTM)
$34,844▼ −2.6% YoY
Free Cash Flow (TTM)
$25,668▼ −2.6% YoY
About CANDEL THERAPEUTICS INC
A company profile for CANDEL THERAPEUTICS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
56/100
Analyst Price Target
ⓘAverage Target
$845.62
▲ +4.7% Upside
High Target$974.52
Low Target$662.94
Based on 25 analysts
Latest News & Updates
🚀
Barron’s·2h ago
CANDEL THERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift CADL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
CANDEL THERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.